---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-110720"
form_type: "8-K"
ticker: "KMTS"
cik: "0001877184"
company_name: "KESTRA MEDICAL TECHNOLOGIES, LTD."
filed_at: "2026-03-17T23:59:59+00:00"
generated_at: "2026-05-15T10:57:28.726740+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Kestra Medical Q3 FY26 revenue $24.6M (+63% YoY); FY26 guidance raised to $93M

## Summary
- Revenue of $24.6M, up 63% YoY; gross margin expanded to 52.6% from 43.4%.
- Prescriptions written for ASSURE system up 58% to 5,462; driven by market share gains.
- GAAP net loss widened to $34.2M vs $21.8M; adjusted EBITDA loss $21.2M vs $16.3M.
- FY26 revenue guidance increased to $93M, representing 55% growth over FY25.
- Cash and equivalents $291M after December 2025 equity offering of 6.9M shares.

## SEC filing metadata
- accession: 0001193125-26-110720
- form_type: 8-K
- ticker: KMTS
- cik: 0001877184
- company_name: KESTRA MEDICAL TECHNOLOGIES, LTD.
- filed_at: 2026-03-17T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1877184/000119312526110720/0001193125-26-110720-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1877184/000119312526110720/ck0001877184-20260317.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-110720
- JSON: https://secwatch.observer/filing/0001193125-26-110720.json
- Plain text: https://secwatch.observer/filing/0001193125-26-110720.txt

## Key facts
- Earnings Releases
  KESTRA MEDICAL TECHNOLOGIES, LTD. reported the third quarter fiscal 2026, which ended January 31, 2026 results: revenue $24.6 million, net income $34.2 million. Guidance raised.
  - Period: the third quarter fiscal 2026, which ended January 31, 2026
  - Revenue: $24.6 million
  - Net income: $34.2 million
  - Guidance: raised
  - Result: reported results
  source text: and digital healthcare company, today reported financial results for the third quarter fiscal 2026, which ended January 31, 2026. Financial Highlights • Generated revenue of $24.6 million in Q3 FY26, an increase of 63% compared to the prior year period. • Expanded gross margin to 52.6% in Q3 FY26 compared to 43.4% in the prior year period. • Increased FY26 revenue
  evidence_url: https://www.sec.gov/Archives/edgar/data/1877184/000119312526110720/0001193125-26-110720-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.